Pityriasis rosea and pityriasis rosea-like eruption after anti-SARS-CoV-2 vaccination: a report of five cases and review of the literature

Only a few cases of pityriasis rosea (PR)/pityriasis rosea-like eruption (PRLE) after anti-SARS-CoV-2 vaccination have been reported. In the period May 2021- February 2022 we observed five cases of clinically typical PR that appeared 2 to 3 weeks after anti-SARS-CoV-2 vaccination with BNT162b2 (3 pa...

Descripción completa

Detalles Bibliográficos
Autores principales: Veraldi, Stefano, Boneschi, Vinicio, Cusini, Marco, Maronese, Carlo Alberto
Formato: Online Artículo Texto
Lenguaje:English
Publicado: PAGEPress Publications, Pavia, Italy 2022
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10099291/
https://www.ncbi.nlm.nih.gov/pubmed/37063394
http://dx.doi.org/10.4081/dr.2022.9503

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10099291/
https://www.ncbi.nlm.nih.gov/pubmed/37063394
http://dx.doi.org/10.4081/dr.2022.9503

Ejemplares similares